Indian Council of Agricultural Research


ICAR CMFRI s two seaweed based nutraceuticals commercialised

ICAR CMFRI s two seaweed-based nutraceuticals commercialised

ICAR-Central Marine Fisheries Research Institute (CMFRI) has commercialised patent protected technologies of two seaweed-based nutraceutical products: one to boost anti-viral immunity and the other to combat high cholesterol or dyslipidemia.Dr A Gopalakrishnan, Director of ICAR-CMFRI signed a license agreement with Joby George, Managing Partner of Pioneer Pharmaceuticals Ltd, a wellness and pharmaceutical company based in Kochi for commercial production and marketing of these products. Bioactive pharmacophore leads from seaweeds were used to develop these two nutraceutical products, which are a 100% natural blend of highly nutritious bioactive ingredients extracted with eco-friendly ‘green’ technology.  Dr Kajal Chakraborty, Head of the Marine Biotechnology, Fish Nutrition and Health Division of ICAR-CMFRI led the research works to develop these products.


Anti-viral immunity booster

The product CadalminTM Immunalgin extract or CadalminTM IMe could be used against post COVID complications as this nutraceutical has antiviral properties against delta variant of SAARS CoV-2 virus. It elevates immune responses by the regulation of the secretion of pro-inflammatory cytokines and chemokines.  It will act as a good naturally derived alternative source for health benefits against inflammation and autoimmune disorders.

Natural remedy for high cholesterol

CadalminTM Antihypercholesterolemic extract or CadalminTM ACe has proved to be a natural remedy to combat dyslipidemia and hypercholesterolemic disorders. Dyslipidemia is the presence of high levels of cholesterol in the blood. This was developed using seaweed concentrate with anti-dyslipidemic activities following a sequel of purification steps.

These nutraceutical products contain 100% natural marine bioactive ingredients from selected seaweeds, which are commonly available in the Indian coastal waters.

Dr Gopalakrishnan said that ICAR-CMFRI is in the process of developing more health products from seaweeds towards their utilization based on the National Policy to harness the potential of this natural wealth of Indian coastal waters. Seaweeds are termed as the ‘wonder herbs of the ccean’ and are the sources of future pharmaceuticals and food for human well-being.

Besides these two products, the institute has successfully brought out nutraceuticals targeting a range of lifestyle diseases, such as type-2 diabetes, arthritis, hypertension, hypothyroidism, osteoporosis and fatty liver.

These products would be made available in the market within a six month time-frame by the Pioneer Pharmaceuticals.


Union Minister of Fisheries, Animal Husbandry and Dairying unveils ICAR CMFRIs study on Marine Fish Stock Status of India 2022

Union Minister of Fisheries, Animal Husbandry and Dairying unveils ICAR CMFRIs study on Marine Fish Stock Status of India 2022

Shri Parshottam Rupala, Hon’ble Union Minister of Fisheries, Animal Husbandry and Dairying has unveiled a remarkable study report by the ICAR-Central Marine Fisheries Research Institute (ICAR-CMFRI) on 31st August 2023 during the ‘Sagar Parikrama phase VIII at Kanyakumari, Tamil Nadu.The report titled ‘Marine Fish Stock Status of India 2022’ reveals that India’s marine fish stock is healthy and sustainable. According to the study, a resounding 91.1% of the 135 fish stocks assessed in 2022 were deemed healthy, marking a significant milestone in India's efforts to maintain the sustainability of its marine fisheries. The report also highlighted the substantial reduction in unsustainable practices, with just 4.4% of the stocks facing overfishing.These findings are poised to substantiate India's position at the World Trade Organization (WTO) and are anticipated to have a favourable impact on the country's stance in international trade negotiations. This report is also expected to be a game-changer in India’s seafood exports as sustainability has emerged as a key criterion in the global seafood trade. Minister Shri. Rupala also released ICAR-CMFRI’s special publication titled ‘Good Management Practices in Seaweed Farming’ on the occasion. ICAR-CMFRI has identified 333 prospective seaweed farming sites covering 23,950 hectares, aimed at horizontal expansion of seaweed cultivation. India has a seaweed production potential of 9.88 million t wet weight per year while the current production stands at merely 52,107 t wet weight per year. Seaweed farming has the potential to provide revenue up to Rs. 13.28 lakhs per hectare in a year on a dry weight basis.


On the previous day, 30th August 2023, Union Minister Shri. Prashottam Rupala visited the Vizhinjam Regional Centre of ICAR-CMFRI, Vizhinjam, Kerala. Addressing the gathering at the Centre, the Minister emphasised that offshore cage farming is the immediate focus of the country using bigger cages. “Cage fish farming is to be expanded to the offshore waters with better cage designs having a size of 30 diameters or above that can accommodate lakhs of juveniles”, Shri Rupala said. He added that ICAR-CMFRI should spearhead research and development efforts in creating these advanced cages. The Minister also urged ICAR-CMFRI to expand seed production technologies for finfishes to all the coastal states utilising the public-private-partnership (PPP) mode. Shri Parshottam Rupala also underscored the untapped potential of Pearl Oyster production, urging ICAR-CMFRI to take a proactive role in scaling up its production in a bigger way. Dr L Murugan, Hon’ble Minister of State for Fisheries, Animal Husbandry and Dairying and Shri. V Muraleedharan, Hon’ble Minister of State for External Affairs and Parliamentary Affairs accompanied Shri Parshottam Rupala.